Sphera Funds Management Ltd. Macrogenics Inc Transaction History

Sphera Funds Management Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $2.61 Million - $6.02 Million	235,000 New	235,000 $4.23 Million
Q2 2018 Aug 13, 2018	SELL	$19.78 - $24.67 $2.67 Million - $3.33 Million	-135,000 Closed	0 $0
Q1 2018 May 10, 2018	SELL	$18.89 - $32.46 $69,893 - $120,102	-3,700 Reduced 2.67%	135,000 $3.4 Million
Q4 2017 Feb 12, 2018	SELL	$16.19 - $20.3 $1.13 Million - $1.42 Million	-70,000 Reduced 33.54%	138,700 $2.64 Million
Q3 2017 Nov 09, 2017	BUY	$15.52 - $18.94 $3.24 Million - $3.95 Million	208,700	208,700 $3.86 Million

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $199M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

Stay updated on Sphera Funds Management Ltd. with notifications on news.